idiopathic pulmonary fibrosis

Physical activity and mortality risk in people with interstitial lung disease: a systematic review and meta-analysis
Vânia Patrícia Martins Rocha, Cátia Paixão, Alda Marques

European Respiratory Journal Sep 2021, 58 (suppl 65) PA1810; DOI: 10.1183/13993003.congress-2021.PA1810
A rejuvenation effect of the antifibrotic therapy correlates with lung function improvement in IPF patients
sofia pavanello, Manuela Campisi, Filippo Liviero, Davide Biondini, Elisabetta Balestro, Paolo Spagnolo

European Respiratory Journal Sep 2021, 58 (suppl 65) PA672; DOI: 10.1183/13993003.congress-2021.PA672
Reliability and validity of the Chester Step Test in people with Interstitial Lung Disease
Ana Alves, Ana Oliveira, Pedro G Ferreira, Alda Marques

European Respiratory Journal Sep 2021, 58 (suppl 65) PA766; DOI: 10.1183/13993003.congress-2021.PA766
Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice
Robert J J O'Donoghue, Caitlin O'Brien, Mun Joo Chuei, Vanessa Welk, Thomas Jaquin, Goran Martic, Ellie H-J Cho, Kathryn Stok, Delaney Haugan, Gabrielle Matschiner, Giuseppe Ciccotosto, Andrew G Jarnicki, Gary P Anderson

European Respiratory Journal Sep 2021, 58 (suppl 65) PA733; DOI: 10.1183/13993003.congress-2021.PA733
Transcriptome profiling reveals a potential role for antagonism of the calcium-sensing receptor in the prophylaxis of idiopathic pulmonary fibrosis
Kasope L. Wolffs, Daniel A. Pass, Beth Mansfield, Richard T. Bruce, Petar A. Popov, Christopher J. Corrigan, Jeremy P.T. Ward, Paul J. Kemp, Benjamin Hope-Gill, Daniela Riccardi

European Respiratory Journal Sep 2021, 58 (suppl 65) PA669; DOI: 10.1183/13993003.congress-2021.PA669
The effect of pulmonary macrophage transplantation in the pulmonary fibrosis of mice
EIKO SUZUKI, Jun Ikari, Masaki Suzuki, Ayako Shimada, Keiko Yamamoto, Nozomi Tanaka, Ayumi Sekine, Seiichiro Sakao, Koichiro Tatsumi, Takuji Suzuki

European Respiratory Journal Sep 2021, 58 (suppl 65) PA730; DOI: 10.1183/13993003.congress-2021.PA730
Effect of Nintedanib in a rat model of bleomycin-induced lung fibrosis: a transcriptome analysis
Martina Bonatti, Vanessa Pitozzi, Paola Caruso, Silvia Pontis, Maria Gloria Pittelli, Caterina Frati, Denise Madeddu, Federico Quaini, Costanza Lagrasta, Maurizio Civelli, Simone Ottonello, Gino Villetti, Marcello Trevisani, Barbara Montanini

European Respiratory Journal Sep 2021, 58 (suppl 65) PA731; DOI: 10.1183/13993003.congress-2021.PA731
Improved assay for the quantification of hydroyproline (collagen) in animal models of Idiopathic Pulmonary Fibrosis
Mary Mcelroy, Jem Davis, Angela Marsden, Pan Filis, Darren Spark, Iain Love

European Respiratory Journal Sep 2021, 58 (suppl 65) PA729; DOI: 10.1183/13993003.congress-2021.PA729
Functional status following pulmonary rehabilitation in patients with interstitial lung disease
Guilherme Rodrigues, Sara Souto-Miranda, Vânia Rocha, Pedro Ferreira, Alda Sofia Pires De Dias Marques

European Respiratory Journal Sep 2021, 58 (suppl 65) PA787; DOI: 10.1183/13993003.congress-2021.PA787
Development of PRS-220, a potential best-in-class, inhaled CTGF/CCN2 inhibitor for the treatment of IPF
Vanessa Welk, Marina Pavlidou, Claudia Wurzenberger, Eva-Maria Hansbauer, Cornelia Wurzenberger, Stefan Grüner, Janet Peper-Gabriel, Thomas Jaquin, Antonio Konitsiotis, Josefine Morgenstern, Josef Prassler, Gabriele Matschiner, Shane Olwill

European Respiratory Journal Sep 2021, 58 (suppl 65) PA732; DOI: 10.1183/13993003.congress-2021.PA732

Main menu

User menu

Search

idiopathic pulmonary fibrosis

Pages

Contact us